First Time Loading...

Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 850.6 DKK -2.58% Market Closed
Updated: May 5, 2024

Novo Nordisk A/S
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novo Nordisk A/S
Research & Development Peer Comparison

Comparables:
HLUN A
ALK B

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Novo Nordisk A/S
CSE:NOVO B
Research & Development
-kr29.4B
CAGR 3-Years
-29%
CAGR 5-Years
-17%
CAGR 10-Years
-10%
H Lundbeck A/S
CSE:HLUN A
Research & Development
-kr3.4B
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Research & Development
-kr607m
CAGR 3-Years
-7%
CAGR 5-Years
-11%
CAGR 10-Years
N/A

See Also

What is Novo Nordisk A/S's Research & Development?
Research & Development
-29.4B DKK

Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Research & Development amounts to -29.4B DKK.

What is Novo Nordisk A/S's Research & Development growth rate?
Research & Development CAGR 10Y
-10%

Over the last year, the Research & Development growth was -35%. The average annual Research & Development growth rates for Novo Nordisk A/S have been -29% over the past three years , -17% over the past five years , and -10% over the past ten years .